Atlas Trials

Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality

Clinical trial NCT05095155 · COMPLETED

Trial details

NCT number
NCT05095155
Sponsor
Asfendiyarov Kazakh National Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
B Cell LeukemiaLymphoma
Start date
2022-04-01
Primary completion
2023-01-20
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.